News
Show me

January 20, 2023
BioSeed 2023 in London
Our CEO, Andreas Jensen, will present at BioSeed in London, UK. Please reach us if you are interested in learning more about our universal labelling platform for theranostics and how it can be applied in your drug development programs. Schedule a meeting with Andreas Ingemann Jensen, PhD Pharm, by contacting him directly.
See you on Monday!

December 31, 2022
Happy New Year 2023 💫
As we start a new year, it is a time for reflection and setting new goals. The new year is a chance to leave the past behind and look toward the future with hope and determination. It is an opportunity to start fresh and make positive changes in our lives. I hope that this new year brings you joy, health, and prosperity and that you are able to achieve all that you set out to do. Happy New Year!

December 9, 2022
Ph.D. Fellowship
We are happy to announce a Ph.D. fellowship collaboration with Dept. of Drug Design and Pharmacology (ILF), University of Copenhagen. Welcome to apply via the Faculty of Health and Medical Sciences, https://healthsciences.ku.dk/
#university #collaboration #health #phd

November 29, 2022
Radiograf Rådet
This year’s Nobel Prize in chemistry prompted the Danish Newspaper Radiograf Rådet to publish a story about the academic research of Dr. Matthias Herth, our very own CSO, using click chemistry. Check it out (in Danish only) 😊 https://lnkd.in/eddXebf2
#clickchemistry #positronemissiontomography #radiotherapy

November 22, 2022
Supply At-211
We are pleased to announce an agreement with Rigshospitalet (The National Hospital of Denmark), Department of Clinical Physiology, Nuclear Medicine & PET to supply us with astatine-211 (At-211) for our development programs.
#hospital #medicine #TAT #alphatherapy #alphaisotopes

October 10, 2022
TRIMT and TETRAKIT
#TRIMT and #TETRAKIT are joining forces to develop 18F-Flutrahexin based on #Nobel Prize awarded #technology. Read more in the press release.
About TRIMT TRIMT GmbH is a clinical-stage company developing novel radiopharmaceuticals to diagnose and treat life-threatening diseases. The company was founded in early 2021 in Radeberg near Dresden (Germany). TRIMT holds a worldwide exclusive license for various new radioligands based on technologies from the Technical University of Munich.

October 6, 2022
ZEIT ONLINE
As an international expert in click chemistry, Dr. Matthias Herth, our CSO at TetraKit Technologies, was asked by ZEIT ONLINE to comment on this year’s Nobel Prize winners in Chemistry.
#future #technology #chemistry #drugdevelopment
Read more about this fascinating new technology with incredible potential for future drug development:
https://lnkd.in/e7nUAePe

October 6, 2022
Click chemistry
Congrats to the Nobel Prize winners, Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless “for developing click chemistry and bioorthogonal chemistry.” TetraKit Technologies concurs with this outstanding decision of the Nobel Prize Committee. Click chemistry is also the core of our TetraKit platform, with broad application in pretargeting or drug delivery strategies. The Noble Prize homepage announced, “It just says click – and the molecules are coupled together.”
We are looking forward to a bright future of click and bioorthogonal chemistry. #future#chemistry#nobelprize
Read more about this year’s Nobel Laureates in Chemistry:
https://lnkd.in/ee6R8J54

October 6, 2022
Nordic Life Science Days
TetraKit Technologies is pitching to the international investor community at Nordic Life Science Invest as one of the rising stars 🌟 #nlsdays #nlsinvest #lifescience #radiopharmaceuticals

May 21, 2022
iSRS conference in Nantes (France)
TetraKit will be attending the iSRS conference in Nantes (France), next week. Please reach out, if you would like to meet with us.

May 9, 2022
1st Cost-Noar Open Meeting
Our CEO and CSO want to thank the organisers from the 1st Cost-Astatine-211 Noar Open Meeting in Gothenburg for a great meeting. We are looking forward to see further progress in the 211At world.